4.65

2.41% -0.13

Sensus Healthcare Inc (SRTS)

Overview News Price History Option Chain Financials Discussions Forecast

Sensus Healthcare Inc stock is traded at $4.65, with a volume of 90,674. It is down -2.41% in the last 24 hours and down -42.48% over the past month. Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

Previous Close:

$4.78

Open:

$4.82

24h Volume:

90,674

Relative Volume:

0.28

Market Cap:

$77.94M

Revenue:

$24.41M

Net Income/Loss:

$485.00K

P/E Ratio:

8.1579

EPS:

0.57

Net Cash Flow:

$-2.37M

1W Performance:

-10.12%

1M Performance:

-42.48%

6M Performance:

-25.83%

1Y Performance:

+12.95%

1-Day Range:

$4.63

$4.95

1-Week Range:

$4.63

$5.24

52-Week Range:

$2.91

$9.3293

Sensus Healthcare Inc Stock (SRTS) Company Profile

Name

Sensus Healthcare Inc

Sector

Healthcare (1188)

Industry

Medical Devices (159)

Phone

561-922-5808

Address

851 BROKEN SOUND PARKWAY NW, BOCA RATON, FL

Employee

Twitter

@sensushealth

Next Earnings Date

2024-11-14

Latest SEC Filings

SRTS's Discussions on Twitter

Compare SRTS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SRTS Sensus Healthcare Inc	4.665	77.94M	24.41M	485.00K	-2.37M	0.57
ABT Abbott Laboratories	140.69	241.69B	41.95B	13.40B	6.35B	7.65
BSX Boston Scientific Corp	105.35	153.75B	16.75B	1.85B	2.37B	1.25
SYK Stryker Corp	397.17	150.24B	22.60B	2.99B	3.49B	7.76
MDT Medtronic Plc	94.57	120.56B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	72.74	42.42B	5.72B	4.17B	490.10M	6.97

Sensus Healthcare Inc Stock (SRTS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-31-25	Initiated	Lake Street	Buy
Nov-15-24	Reiterated	Maxim Group	Buy
Feb-26-21	Upgrade	Northland Capital	Market Perform → Outperform
Dec-16-20	Downgrade	Northland Capital	Outperform → Market Perform
Aug-10-20	Upgrade	Alliance Global Partners	Neutral → Buy
Feb-14-20	Upgrade	Alliance Global Partners	Neutral → Buy
Nov-07-19	Downgrade	B. Riley FBR	Buy → Neutral
Jan-29-19	Downgrade	Northland Capital	Market Perform → Under Perform
Sep-26-18	Initiated	B. Riley FBR	Buy
Nov-03-17	Reiterated	Maxim Group	Buy
Jun-06-17	Initiated	Maxim Group	Buy
Aug-08-16	Initiated	Northland Capital	Outperform

View All

Sensus Healthcare Inc Stock (SRTS) Latest News

Feb 25, 2025

Sensus Healthcare, Inc. (NASDAQ:SRTS) Stock's 27% Dive Might Signal An Opportunity But It Requires Some Scrutiny - Simply Wall St

Feb 25, 2025

Feb 24, 2025

HC Wainwright Forecasts Strong Price Appreciation for Sensus Healthcare (NASDAQ:SRTS) Stock - MarketBeat

Feb 14, 2025

Feb 13, 2025

HC Wainwright Issues Pessimistic Outlook for SRTS Earnings - Defense World

Feb 13, 2025

Feb 12, 2025

Sensus Healthcare resumes share buyback program - MSN

Feb 12, 2025

HC Wainwright Cuts Earnings Estimates for Sensus Healthcare - MarketBeat

Feb 12, 2025

Sensus Healthcare buys back shares - Medical Buyer

Feb 12, 2025

HC Wainwright Issues Pessimistic Estimate for SRTS Earnings - Defense World

Feb 12, 2025

Feb 11, 2025

Sensus Healthcare Resumes Common Stock Repurchase Program - Defense World

Feb 11, 2025

Sensus Healthcare Resumes $3 Million Share Buyback Plan -February 11, 2025 at 09:17 am EST - Marketscreener.com

Feb 11, 2025

Sensus Healthcare Unlocks $3M War Chest for Strategic Share Repurchases | SRTS - StockTitan

Feb 11, 2025

(SRTS) Technical Pivots with Risk Controls - Stock Traders Daily

Feb 11, 2025

FY2028 Earnings Estimate for SRTS Issued By Roth Capital - Defense World

Feb 11, 2025

Sensus Healthcare (NASDAQ:SRTS) Price Target Raised to $12.00 at HC Wainwright - Defense World

Feb 11, 2025

Feb 10, 2025

Sensus Healthcare’s Strong Revenue Growth and Strategic Initiatives Justify Buy Rating - TipRanks

Feb 10, 2025

Feb 09, 2025

Sensus Healthcare anticipates significant revenue from FDA agreements in H2 2025 - MSN

Feb 09, 2025

Sensus Healthcare (NASDAQ:SRTS) Announces Earnings Results, Misses Expectations By $0.01 EPS - MarketBeat

Feb 09, 2025

Feb 08, 2025

Revenue Beat: Sensus Healthcare, Inc. Beat Analyst Estimates By 5.6% - Simply Wall St

Feb 08, 2025

Sensus Healthcare, Inc. Just Beat Revenue By 5.6%: Here's What Analysts Think Will Happen Next - Yahoo Finance

Feb 08, 2025

Feb 07, 2025

Sensus Healthcare Inc (NASDAQ: SRTS) Has Advanced 70.49% In 2025; Is The Share Price Attractive Enough At $10? - Marketing Sentinel

Feb 07, 2025